Generation of parthenogenetic induced pluripotent stem cells from parthenogenetic neural stem cells

Stem Cells

Volumn 27, Issue 12, 2009, Pages 2962-2968

  Do, Jeong Tae ^a   Joo, Jin Young ^b   Han, Dong Wook ^b   Araúzo Bravo, Marcos J ^b   Kim, Min Jung ^a,c   Greber, Boris ^b   Zaehres, Holm ^b   Sobek Klocke, Ingeborg ^b   Chung, Hyung Min ^c   Schöler, Hans R ^b  

^a CHA University   (South Korea)

^b MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

^c CHA Bio and Diostech Co Ltd   (South Korea)

Author keywords

Genomic imprinting; Parthenogenetic maternal iPS cells; Reprogramming

Indexed keywords

KRUPPEL LIKE FACTOR 4; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; EMBRYO; FEMALE; GENE EXPRESSION; GERM LINE; MOUSE; NEURAL STEM CELL; NONHUMAN; ONCOGENE C MYC; PARTHENOGENESIS; PLURIPOTENT STEM CELL;

ANIMALS; CELL SEPARATION; CELLS, CULTURED; EMBRYO, MAMMALIAN; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INDUCED PLURIPOTENT STEM CELLS; MICE; NEURONS; PARTHENOGENESIS; STEM CELLS;

IPS;

EID: 73349126088     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.233     Document Type: Article

References (27)

1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676.
2. Aoi T, Yae K, Nakagawa M et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 2008;321:699-702.
3. Hanna J, Markoulaki S, Schorderet P et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 2008;133:250-264.
4. Stadtfeld M, Brennand K, Hochedlinger K. Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Curr Biol 2008;18:890-894.
5. Eminli S, Utikal J, Arnold K et al. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression. Stem Cells 2008;26:2467-2474.
6. Kim JB, Zaehres H, Wu G et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 2008;454:646-650.
7. Shi Y, Do JT, Desponts C et al. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2008;2:525-528.
8. Horii T, Kimura M, Morita S et al. Loss of genomic imprinting in mouse parthenogenetic embryonic stem cells. Stem Cells 2008;26: 79-88.
9. Do JT, Scholer HR. Nuclei of embryonic stem cells reprogram somatic cells. Stem Cells 2004;22:941-949.
10. Zaehres H, Daley GQ. Transgene expression and RNA interference in embryonic stem cells. Methods Enzymol 2006;420:49-64.
11. McGrath J, Solter D. Completion of mouse embryogenesis requires both the maternal and paternal genomes. Cell 1984;37:179-183.
12. Surani MA, Barton SC. Development of gynogenetic eggs in the mouse: Implications for parthenogenetic embryos. Science 1983;222: 1034-1036.
13. Hasegawa K, Yoshikawa K. Necdin regulates p53 acetylation via Sirtuin1 to modulate DNA damage response in cortical neurons. J Neurosci 2008;28:8772-8784.
14. Lee S, Walker CL, Wevrick R. Prader-Willi syndrome transcripts are expressed in phenotypically significant regions of the developing mouse brain. Gene Expr Patterns 2003;3:599-609.
15. Pereira CM, Sattlegger E, Jiang HY et al. IMPACT, a protein preferentially expressed in the mouse brain, binds GCN1 and inhibits GCN2 activation. J Biol Chem 2005;280:28316-28323.
16. Kim JB, Sebastiano V, Wu G et al. Oct4-induced pluripotency in adult neural stem cells. Cell 2009;136:411-419.
17. Jaenisch R, Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 2008;132:567-582.
18. Xiong Z, Laird PW. COBRA: A sensitive and quantitative DNA methylation assay. Nucleic Acids Res 1997;25:2532-2534.
19. Kanatsu-Shinohara M, Inoue K, Lee J et al. Generation of pluripotent stem cells from neonatal mouse testis. Cell 2004;119:1001-1012.
20. Yoshida Y, Takahashi K, Okita K et al. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 2009;5:237-241.
21. Hong H, Takahashi K, Ichisaka T et al. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 2009;460:1132-1135.
22. Kawamura T, Suzuki J, Wang YV et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 2009;460:1140-1144.
23. Li H, Collado M, Villasante A et al. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 2009;460:1136-1139.
24. Marión RM, Strati K, Li H et al. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 2009;460:1149-1153.
25. Utikal J, Polo JM, Stadtfeld M et al. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 2009;460:1145-1148.
26. Park IH, Arora N, Huo H et al. Disease-specific induced pluripotent stem cells. Cell 2008;134:877-886.
27. Nakao M, Sasaki H. Genomic imprinting: Significance in development and diseases and the molecular mechanisms. J Biochem 1996;120:467-473.